Esketamine in Microelectrode Recording-guided Subthalamic Deep-Brain Stimulation for Parkinson's Disease（ASPIRE）：A Randomized Controlled, Double-blind Study

Phase: NA | Sponsor: Beijing Tiantan Hospital | Compound: Ketamine

Status

recruiting

Institution

Beijing Tiantan Hospital

Start date

2024-08-09

End date

2026-01-31

Registry ID

NCT06543563

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.